Literature DB >> 6490637

Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination.

J M Krueger, M L Karnovsky, S A Martin, J R Pappenheimer, J Walter, K Biemann.   

Abstract

The structures of components of the sleep-promoting material purified from human urine were established by fast atom bombardment-mass spectrometry, as reported in the accompanying paper (Martin, S. A., Karnovsky, M. L., Krueger, J. M., Pappenheimer, J. R., and Biemann, K. (1984) J. Biol. Chem. 259, 12652-12658). We report here that two substances isolated from that preparation, viz. N-acetylglucosaminyl-1,6 -anhydro-N-acetylmuramyl-Ala-gamma-Glu-diaminopimelyl-Ala) and that compound lacking the terminal alanine, are active as somnogens. Cerebro-intraventricular administration of 1 pmol of the glycotetrapeptide was sufficient to induce prolonged excess sleep in rabbits. A similar substance obtained from Brevibacterium divaricatum in which the free carboxyls of the glutamic and diaminopimelic moieties, indicated above, were amidated (N-acetylglucosaminyl-1,6-anhydro-N-anhydromura-myl-Ala-iso- Gln- epsilon-amido-diaminopimelyl -Ala-Ala) was not active as a promoter of slow-wave sleep. Deamidation of this peptide to a mixture of the free dicarboxylic forms produced a somnogenic substance. Our findings show that in addition to the muramyl form of peptidoglycan monomers, the anhydro muramyl form, with no reducing end, is compatible with somnogenic activity. Furthermore, the data obtained with a natural product amplify our earlier observations with smaller synthetic molecules of the importance of amidation/deamidation in the structure-activity relationships of muramyl peptides.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490637

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Endogenous synthesis of peptidoglycan in eukaryotic cells; a novel concept involving its essential role in cell division, tumor formation and the biological clock.

Authors:  C A Roten; D Karamata
Journal:  Experientia       Date:  1992-10-15

Review 2.  Role of biological membranes in slow-wave sleep.

Authors:  M L Karnovsky
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

3.  Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response.

Authors:  Dipti Karmarkar; Kenneth L Rock
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

4.  Gut microbes extend reach to systemic innate immunity.

Authors:  Dana J Philpott; Stephen E Girardin
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

5.  Trace levels of peptidoglycan in serum underlie the NOD-dependent cytokine response to endoplasmic reticulum stress.

Authors:  Raphael Molinaro; Tapas Mukherjee; Robert Flick; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2019-04-17       Impact factor: 5.157

Review 6.  Activation of B cells by non-canonical helper signals.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  EMBO Rep       Date:  2012-08-07       Impact factor: 8.807

7.  Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide.

Authors:  L T Meltzer; K A Serpa; W H Moos
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Peptidoglycan fragments decrease food intake and body weight gain in rats.

Authors:  K J Biberstine; R S Rosenthal
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Murein-metabolizing enzymes from Escherichia coli: existence of a second lytic transglycosylase.

Authors:  H Engel; A J Smink; L van Wijngaarden; W Keck
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

10.  Murein-metabolizing enzymes from Escherichia coli: sequence analysis and controlled overexpression of the slt gene, which encodes the soluble lytic transglycosylase.

Authors:  H Engel; B Kazemier; W Keck
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.